140 related articles for article (PubMed ID: 15956257)
21. Pax3 stimulates p53 ubiquitination and degradation independent of transcription.
Wang XD; Morgan SC; Loeken MR
PLoS One; 2011; 6(12):e29379. PubMed ID: 22216266
[TBL] [Abstract][Full Text] [Related]
22. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
Yan X; Fraser M; Qiu Q; Tsang BK
Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
[TBL] [Abstract][Full Text] [Related]
23. PAX3 expression in primary melanomas and nevi.
Plummer RS; Shea CR; Nelson M; Powell SK; Freeman DM; Dan CP; Lang D
Mod Pathol; 2008 May; 21(5):525-30. PubMed ID: 18327212
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells.
Song JH; Song DK; Herlyn M; Petruk KC; Hao C
Clin Cancer Res; 2003 Sep; 9(11):4255-66. PubMed ID: 14519653
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of alternative isoforms of the transcription factor PAX3 in melanocytes in vitro.
Wang Q; Kumar S; Slevin M; Kumar P
Cancer Res; 2006 Sep; 66(17):8574-80. PubMed ID: 16951170
[TBL] [Abstract][Full Text] [Related]
26. Expression of PAX 3 alternatively spliced transcripts and identification of two new isoforms in human tumors of neural crest origin.
Parker CJ; Shawcross SG; Li H; Wang QY; Herrington CS; Kumar S; MacKie RM; Prime W; Rennie IG; Sisley K; Kumar P
Int J Cancer; 2004 Jan; 108(2):314-20. PubMed ID: 14639621
[TBL] [Abstract][Full Text] [Related]
27. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
28. PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas).
Medic S; Ziman M
PLoS One; 2010 Apr; 5(4):e9977. PubMed ID: 20421967
[TBL] [Abstract][Full Text] [Related]
29. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3.
Watanabe A; Takeda K; Ploplis B; Tachibana M
Nat Genet; 1998 Mar; 18(3):283-6. PubMed ID: 9500554
[TBL] [Abstract][Full Text] [Related]
30. Aberrant PAX3 and PAX7 expression. A link to the metastatic potential of embryonal rhabdomyosarcoma and cutaneous malignant melanoma?
Blake J; Ziman MR
Histol Histopathol; 2003 Apr; 18(2):529-39. PubMed ID: 12647804
[TBL] [Abstract][Full Text] [Related]
31. Nuclear orphan receptor TR3/Nur77 mediates melanoma cell apoptosis.
Yu H; Kumar SM; Fang D; Acs G; Xu X
Cancer Biol Ther; 2007 Mar; 6(3):405-12. PubMed ID: 17297306
[TBL] [Abstract][Full Text] [Related]
32. Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene.
Ayyanathan K; Fredericks WJ; Berking C; Herlyn M; Balakrishnan C; Gunther E; Rauscher FJ
Cancer Res; 2000 Oct; 60(20):5803-14. PubMed ID: 11059777
[TBL] [Abstract][Full Text] [Related]
33. Short interfering RNA directed against the SLUG gene increases cell death induction in human melanoma cell lines exposed to cisplatin and fotemustine.
Vannini I; Bonafe M; Tesei A; Rosetti M; Fabbri F; Storci G; Ulivi P; Brigliadori G; Amadori D; Zoli W
Cell Oncol; 2007; 29(4):279-87. PubMed ID: 17641412
[TBL] [Abstract][Full Text] [Related]
34. P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation.
Avery-Kiejda KA; Bowden NA; Croft AJ; Scurr LL; Kairupan CF; Ashton KA; Talseth-Palmer BA; Rizos H; Zhang XD; Scott RJ; Hersey P
BMC Cancer; 2011 May; 11():203. PubMed ID: 21615965
[TBL] [Abstract][Full Text] [Related]
35. Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins.
Bernasconi M; Remppis A; Fredericks WJ; Rauscher FJ; Schäfer BW
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13164-9. PubMed ID: 8917562
[TBL] [Abstract][Full Text] [Related]
36. Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines.
Barr FG; Fitzgerald JC; Ginsberg JP; Vanella ML; Davis RJ; Bennicelli JL
Cancer Res; 1999 Nov; 59(21):5443-8. PubMed ID: 10554014
[TBL] [Abstract][Full Text] [Related]
37. PAX3 and SOX10 activate MET receptor expression in melanoma.
Mascarenhas JB; Littlejohn EL; Wolsky RJ; Young KP; Nelson M; Salgia R; Lang D
Pigment Cell Melanoma Res; 2010 Apr; 23(2):225-37. PubMed ID: 20067553
[TBL] [Abstract][Full Text] [Related]
38. Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis.
Ho CK; Li G
Br J Dermatol; 2005 Nov; 153(5):900-10. PubMed ID: 16225598
[TBL] [Abstract][Full Text] [Related]
39. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
Zhang MC; Hu CP; Chen Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
[TBL] [Abstract][Full Text] [Related]
40. G3139 induces cell death by caspase-dependent and -independent apoptosis on human melanoma cell lines.
Nakamura S; Inui M; Kamei T; Nakase M; Okumura K; Tagawa T
Oncol Rep; 2006 Jun; 15(6):1563-8. PubMed ID: 16685396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]